Clement Trempe. Show Affiliations »
Abstract
Entities: Chemical
Mesh： See more » Angiogenesis Inhibitors/adverse effectsAngiogenesis Inhibitors/therapeutic useAntibodies, Monoclonal/adverse effectsAntibodies, Monoclonal/therapeutic useAntibodies, Monoclonal, HumanizedCardiovascular Diseases/mortalityHumansInjections, IntraocularRanibizumabRisk FactorsVascular Endothelial Growth Factor A/antagonists & inhibitorsWet Macular Degeneration/drug therapyWet Macular Degeneration/prevention & control
Substances： See more » Angiogenesis InhibitorsAntibodies, MonoclonalAntibodies, Monoclonal, HumanizedVascular Endothelial Growth Factor ARanibizumab
Year: 2011 PMID： 21306264 DOI： 10.1056/NEJMc1013316
Source DB: PubMed Journal: N Engl J Med ISSN： 0028-4793 Impact factor: 91.245